Ads by Google
Researchers implant embryonic cells into damaged hearts and prevent life-threatening heart arrhythmias.
Scientists have determined that stem cells transplanted into a damaged heart can increase the presence of oxygen at the site of injury.
A new test could give doctors a head start in diagnosing those patients most likely to suffer a heart attack.
New study is significant because it marks the commencement of Amarin's cardiovascular development program and potentially addresses a major medical need.
Most people with heart disease have other ailments, including some that require surgery.
Abbott to Present Comprehensive Safety and Efficacy Data on XIENCE V Drug Eluting Heart Stent to FDA Advisory Committee on November 29.
Sixty years ago, Americans smoked, drank and ate too much of the wrong things, then died of heart disease and stroke.
62-year-old Luther Roden is the first in east Texas to benefit from a heart bypass procedure done totally endoscopically using the da Vinci Robotic Surgical System.
Cardica presented data evaluating the patency, or openness, of bypass grafts connecting the internal mammary artery to the left anterior descending artery using the C-Port xA or Flex A Distal Anastomosis Systems.
Researchers have identified another hunting danger - the hidden danger of a heart attack among men with risk factors and known heart disease.
Scientists have determined how cardiac cells die just as emergency treatments restore blood flow to a heart in distress.
Synvista Therapeutics announced dosing of the first patient in BENEFICIAL trial, a novel compound designed to act as an AGE-cross-link breaker, in patients with chronic heart failure.
The improvement of services for cardiac patients in Wales received a major boost.
Investigational agent of Astellas Pharma US vernakalant hydrochloride increased conversion to normal heart rhythm in patients with atrial fibrillation.
Women with implantable cardioverter defibrillators fare less well than their male counterparts.
People with diabetes who have asymptomatic heart disease may be able to vastly improve the flow of blood to their hearts without surgical intervention.
Some University of Michigan Health System pediatric and adult heart patients are affected by a Medtronic heart device recall.
Nile Therapeutics announced results from a Phase 1a clinical study of CD-NP, Nile's selective NPR-B agonist being developed for the treatment of heart failure. The results of this study will be included in the Company's presentation today at the BIO Investor Forum in San Francisco, CA.
Astellas Pharma announced that the investigational agent vernakalant hydrochloride increased conversion to normal heart rhythm.
American Heart Association's free online grocery list builder to create a heart-healthy shopping list filled with products bearing the heart-check mark.
World Heart Day urges parents to set a good example and ensure that children adopt healthy-heart habits early in life.
Older women who experience at least one full-blown panic attack may have an increased risk of having a heart attack or stroke and an increased risk of death in the next five years.
Thousands of heart patients in the Greater New York region will receive top quality, comprehensive cardiac care in an innovative cardiovascular program.
Women and blacks are less likely than white men to receive implantable heart defibrillators.
Clinical trials show that ICDs (implantable cardioverter-defibrillator) save lives, so the sex difference in treatment rates is worrisome.
Many Americans hospitalized for heart failure are coming up short when it comes to getting the therapy they need - especially women and minorities.
Signalife has completed in-house testing and technological evaluation of various new modules for its holter and intra- cardiac monitors - items.
HSFC and CIHR launched of a groundbreaking new international study to assess the impact of heart and stroke (cardiovascular) research.
A new PBS series from filmmaker David Grubin - The Mysterious Human Heart - that explores the body's perpetual motion machine and how we cope with coronary diseases, to premier October 15, 2007.
A research is challenging conventional thinking on how the cholesterol-reducing drugs statins benefit heart patients.
